Mabcampath

Mabcampath

Product Details:

X

Product Description

MabCampath is used to treat patients with B-cell chronic lymphocytic leukaemia (B-CLL), a cancer of a type of white blood cell called B lymphocytes. MabCampath is used in patients for whom treatment combinations including fludarabine (another medicine used in leukaemia) are not appropriate. The medicine can only be obtained with a prescription.
  • Medicine Name: Mabcampath
  • Generic Name: Alemtuzumab
  • Approval Date: 2001
  • Company Name: Genzyme Corporation
  • Available as (Form & Strength): 30 mg/1 mL single use vial

PRISSM PHARMA

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



Back to top
PRISSM PHARMA All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.